Dörte Herich‐Terhürne

Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial

Alexander Röth, Martin Bommer, Andreas Hüttmann et al. · Blood Advances · 2018 · 113 citations · Full text

Medicine, Hematology, Pharmacology +17

Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab

Ferras Alashkar, Colin Vance, Dörte Herich‐Terhürne et al. · Annals of Hematology · 2017 · 32 citations

Life Sciences, Hematology, Immunology +15

Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)

Alexander Röth, Martin Bommer, Andreas Hüttmann et al. · Blood · 2015 · 21 citations

Life Sciences, Immunology, Internal Medicine +14

Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation

Ferras Alashkar, Fuat H. Saner, Colin Vance et al. · Frontiers in Medicine · 2020 · 19 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab

Ferras Alashkar, Scott T. Rottinghaus, Colin Vance et al. · PLoS ONE · 2020 · 11 citations · Full text

Life Sciences, Hematology, Immunology +16